C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/42 (2006.01) A61K 31/425 (2006.01) A61K 31/435 (2006.01) A61K 31/535 (2006.01) A61K 31/695 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2227829
Compound represented by general formula <u>I</u> or pharmaceutically acceptable salts or hydrates thereof, having the activity of inhibiting the production of prostaglandin E2 by inhibiting intracellular phospholipase A2.
Composé représenté par la formule générale <u>I</u> ou sels ou hydrates pharmaceutiquement acceptables dudit composé, possédant une activité d'inhibition de la production de prostaglandine E¿2? par inhibition de la phospholipase A¿2? intracellulaire.
Kato Toshiyuki
Ohtani Mitsuaki
Seno Kaoru
Watanabe Fumihiko
Anthera Pharmaceuticals Inc.
Kirby Eades Gale Baker
Shionogi & Co. Ltd.
LandOfFree
Pyrrolidine derivatives having phospholipase a2 inhibitory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine derivatives having phospholipase a2 inhibitory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine derivatives having phospholipase a2 inhibitory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1979011